NCT07222605Enrolling by invitation
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
Research Study Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
Primary Objective: The primary objective of this pilot study is to gain voluntary feedback from patients with neurological diseases and their caregivers regarding their experiences using the MemorEM head device. This information may help in new designs of the MemorEM and suggest ways to increase compliance for future clinical trials and eventual commercialization. Secondary Objective: The secondary objective is to note areas of potential improvement in the progression of the subject's neurological disease and identify the potential for the MemorEM to treat neurological diseases other than Alzheimer's disease. The investigators are also interested in Alzheimer's variants like those with ApoE4 alleles (none of the participants in the 8-person pilot were Apo-E4 positive), known mutations causing early onset Alzheimer's, and Posterior Cortical Atrophy.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 8 Jul 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 15 Dec 2027
- Lead sponsor
- eQ8Health Corporation d/b/a CareONE Concierge
- NCT number
- NCT07222605
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 1 Dec 2025 to the primary completion date, 15 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of metal implants in the head, except for metal dental implants
- Patient has implanted medication pumps unless cleared by physician
Other illness
- Patient has Seizures, Epilepsy, uncontrolled Depression, uncontrolled Bipolar disorder, psychotic disorders, alcoholism or drug addiction
- Patient has hypertension that is unresponsive to anti-hypertensive medications
- Patient has significant heart disease, as determined by a physician
Who the study is looking for
- Patient diagnosed with a neurological disease involving aggregated proteins such as Alzheimer's and its variants, Parkinson's, Frontotemporal dementia, Amyotrophic lateral sclerosis, Tauopathies, and other related neurological diseases.
- Presence of a caregiver(s) responsible for ensuring treatment compliance and potentially with authority to make medical decisions for the patient if the patient is not competent to make those decisions.
- A statement from each patient's physician that indicates the patient has the ability to understand and consent on their own AND they have the willingness to sign CareONE's patient consent.
Age in the registry: 45 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CareONE Concierge Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.